MarketLens
Sign Up

Natera’s Sky-High Valuation Prompts Founder Profit-Taking Despite Innovation Wins

1 months ago
SHARE THIS ON:

Natera’s Sky-High Valuation Prompts Founder Profit-Taking Despite Innovation Wins

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 months ago

Executive Dumps Over 14,000 Shares of Biotech Stock, Valued at $2.3 Million

Biotech executive Ian Clark sold 14,000 shares valued at $2.3 million, after exercising options at $50.57 while the precision oncology company trades near $160 per share.
Stock News1 months ago

Natera Shares Soar Over 20% To All-Time High, Bolstering Co-Founder's Billionaire Status

Natera shares rose over 20% to an all-time high, after a strong year-to-date gain of 40.6% from ~$228. The stock's 2025 low was $182.65 in late March, boosting co-founder's billionaire status.
Stock News1 months ago

Natera Submits Signatera™ to Japan's PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer

Natera submitted Signatera to Japan's PMDA for approval as a companion diagnostic in muscle-invasive bladder cancer, following its June approval in colorectal cancer. Approval could expand its Japanes...

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

BABA 13-DAY DEADLINE ALERT: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 5, 2026 Lead Plaintiff Deadline

Stock News2 hours ago

Nasdaq Scores Record As Oil Eases; Apple Tests Buy Point

Stock News2 hours ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alibaba Group Holding Limited of Class Action Lawsuit and Upcoming Deadlines – BABA

Stock News2 hours ago

Meta Was the Worst AI Lab

Stock News3 hours ago

Why Apple could soon join Nvidia in the exclusive $5 trillion club